
|Articles|February 15, 2004
Ophthalmology gets with the program
As part of its commitment to the field of ophthalmology, Pfizer Inc. has developed and funded several philanthropic programs in the area of eye care.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Coave Therapeutics reveals lead gene therapy program, CoTx-10
2
Foundation Fighting Blindness releases 4-year RUSH2A data to public
3
Opus Genetics doses first patient in phase 1/2 clinical trial, BIRD-1, evaluating OPGx-BEST1
4
Harrow completes acquisiton of Melt Pharmaceuticals
5


















































.png)


